Rigel Pharmaceuticals (NASDAQ:RIGL) PT Raised to $4.00

Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) had its target price boosted by research analysts at Citigroup from $3.00 to $4.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Citigroup’s target price points to a potential upside of 154.78% from […]

Leave a Reply

Your email address will not be published.

Previous post comScore (NASDAQ:SCOR) Price Target Cut to $25.00
Next post Ross Stores (NASDAQ:ROST) Price Target Raised to $165.00